Building Patient Engagement and Secure Drug Discovery - Data Privacy, Compliance, and Security

January 22, 2020

This article originally appears in European Biopharmaceutical Review January 2020, pages 60-62. © Samedan Ltd

Much has been made of the trials and tribulations of complying with data regulations; however, Paul Drake at Signant Health argues there may be significant opportunities to be gained for clinical trials from data compliance.

Previous Guide
Measuring Subjective Outcomes Objectively: How Technology Can Boost Data Quality and Endpoint Reliability
Measuring Subjective Outcomes Objectively: How Technology Can Boost Data Quality and Endpoint Reliability

Dr Todd Everhart speaks to the Journal of mHealth about the need to improve endpoint quality, and how techn...

Next Flipbook
Delving into eConsent: Industry Survey Reinforces Patient Centricity
Delving into eConsent: Industry Survey Reinforces Patient Centricity

Signant conducted an electronic informed consent (eConsent) survey to obtain insights from sponsors and CR...